| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/01/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Common Stock | 18.5k | $0.00 | $0 | | 02/28/2023 |
| 02/28/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 718 | $28.00 | $20.1k | | 02/28/2023 |
| 01/05/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 734 | $29.26 | $21.5k | | 01/05/2023 |
| 12/19/2022 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 461 | $30.03 | $13.8k | | 12/19/2022 |
| 02/28/2022 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Common Stock | 8k | $0.00 | $0 | | 02/28/2022 |
| 02/02/2022 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 805 | $45.03 | $36.2k | | 02/02/2022 |
| 01/31/2022 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 626 | $45.94 | $28.8k | | 01/31/2022 |
| 01/07/2022 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 263 | $50.63 | $13.3k | | 01/07/2022 |
| 01/05/2022 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 738 | $50.69 | $37.4k | | 01/05/2022 |
| 12/20/2021 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 467 | $55.42 | $25.9k | | 12/20/2021 |
| 02/02/2021 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Common Stock | 8.9k | $0.00 | $0 | | 02/02/2021 |
| 01/29/2021 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 637 | $46.67 | $29.7k | | 01/29/2021 |
| 01/07/2021 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 237 | $50.97 | $12.1k | | 01/07/2021 |
| 01/05/2021 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 746 | $50.02 | $37.3k | | 01/05/2021 |
| 12/18/2020 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Common Stock | 5k | $0.00 | $0 | | 12/18/2020 |
| 12/18/2020 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Employee Stock Option (Right to Buy) | 10k | $48.09 | $480.9k | | 12/18/2020 |